MIR12129: A Non-Coding RNA Molecule as A Cancer Drug Target and Biomarker

MIR12129: A Non-Coding RNA Molecule as A Cancer Drug Target and Biomarker

MicroRNA 12129 (MIR12129) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. MIR12129 is a key regulator of cell proliferation and has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and cell-cell communication.

The discovery of MIR12129 as a potential drug target comes from a team of researchers at the University of California, San Diego (UCSD). The researchers identified MIR12129 as a promising target for small molecule inhibitors because it is expressed in high levels in many tissues and cells, and because it is involved in a wide range of cellular processes.

To confirm the potential of MIR12129 as a drug target, the researchers conducted a series of experiments to determine its function in cell proliferation and apoptosis. The results of these experiments showed that MIR12129 was involved in the regulation of cell growth and apoptosis, and that it played a role in the development of cancer.

The researchers also used MIR12129 as a biomarker to study the effects of drugs on cancer cells. They found that MIR12129 was a sensitive target for small molecule inhibitors, and that inhibiting its activity could lead to the inhibition of cell proliferation and apoptosis in cancer cells.

In addition to its potential as a drug target, MIR12129 has also been identified as a potential biomarker for cancer. The researchers found that MIR12129 was expressed in a wide range of cancer types, including breast, lung, and ovarian cancer. They also found that MIR12129 was associated with the development of cancer, and that inhibiting its activity could lead to the inhibition of cancer cell proliferation.

The identification of MIR12129 as a potential drug target and biomarker has important implications for the development of new cancer therapies. The researchers are currently working on identifying small molecule inhibitors that can specifically target MIR12129, and they are exploring the potential of these inhibitors for the treatment of cancer.

In conclusion, MIR12129 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for cancer. Its expression is high in many tissues and cells, and it is involved in a wide range of cellular processes, including cell growth, apoptosis, and cell-cell communication. The discovery of MIR12129 as a potential drug target and biomarker has important implications for the development of new cancer therapies. Further research is needed to understand its full function and potential as a drug and biomarker.

Protein Name: MicroRNA 12129

More Common Targets

MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301